Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: A brief review

CMAJ. Canadian Medical Association Journal

Volumn 170, Issue 5, 2004, Pages 821-824

  Wilson, Sarah E ^a   Watson, Henry G ^b   Crowther, Mark A ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMIODARONE; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CARDIAC AGENT; CIMETIDINE; CLOFIBRATE; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCONAZOLE; GASTROINTESTINAL AGENT; ISONIAZID; METRONIDAZOLE; MICONAZOLE; OMEPRAZOLE; PHENYLBUTAZONE; PHYTOMENADIONE; PIROXICAM; PLACEBO; PROPAFENONE; PROPRANOLOL; SULFINPYRAZONE; VITAMIN K GROUP; WARFARIN;

ALCOHOL CONSUMPTION; ANTICOAGULATION; BLEEDING; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; GENITOURINARY BLEEDING; HEALTH CARE PERSONNEL; HEART INFARCTION; HUMAN; INJECTION; INTERNATIONAL STANDARD UNIT; LIVER DYSFUNCTION; LOW DRUG DOSE; PATIENT; PATIENT COMPLIANCE; PATIENT MONITORING; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; THROMBOSIS; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 1542373516     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1030478     Document Type: Review

References (35)

1. McMahan DA, Smith DM, Carey MA, Zhou XH. Risk of major hemorrhage for outpatient treatment with warfarin. J Gen Intern Med 1998;13(5):311-6.
2. Samsa GP, Matchar DB, Goldstein LB, Bonito AJ, Lux LJ, Witter DM, et al. Quality of and coagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med 2000;160(7):967-73.
3. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340(12):901-7.
4. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996;348(7372):423-8.
5. Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002;325(7372):1073-5.
6. Hylek EM, Chang Y, Skates SJ, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Ann Intern Med 2000;160(11):1612-7.
7. Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003;349(12):1133-8.
8. Hirsh J, Dalen JE, Anderson DR, Pollex L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range [review]. Chest 2001;119(1 Suppl):8S-21S.
9. White RH, Minton SM, Andya MD, Hutchinson R. Temporary reversal of anticoagulation using oral vitamin K. J Thromb Thrombolysis 2000;10(2):149-53.
10. Pengo V, Banzato A, Garelli E, Zasso A, Biasiolo A. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation. Blood Coagul Fibrinolysis 1993;4(5):739-41.
11. Wentzien TH, O'Reilly RA, Kearns PJ. Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged. Chest 1998;114(6):1546-50.
12. Penning-ran Beest FJ, Rosendaal FR, Grobbee DE, van Meegen E, Stricker BH. Course of the International Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon. Br J Haematol 1999;104(2):241-5.
13. Fondevila CG, Grosso SH, Santarelli MT, Pinto MD. Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarin discontinuation. A prospective, randomized, open study. Blood Coagul Fibrinolysis 2001;12(1):9-16.
14. Ortin M, Olalla J, Marco F, Velasco N. Low-dose vitamin K1 versus short-term withholding of acenocoumarol in the treatment of excessive anticoagulation episodes induced by acenocoumarol. A retrospective comparative study. Haemostasis 1998;28(2):57-61.
15. Cosgriff SW. The effectiveness of an oral vitamin K1 in controlling excessive hypoprothrombinemia during anticoagulant therapy. Ann Intern Med 1956;45 (1):14-22.
16. Poli D, Antonucci E, Lombardi A, Gensini GF, Abbate R, Prisco D, et al. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation. Haematologica 2003;88(2):237-8.
17. Harrell CC, Kline SS. Oral vitamin K1: an option to reduce warfarin's activity. Ann Pharmacother 1995;29(12):1228-32.
18. Cruickshank J, Ragg M, Eddey D. Warfarin toxicity in the emergency department: recommendations for management. Emerg Med (Fremantle) 2001;13(1):91-7.
19. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med 1997;126 (12):959-62.
20. Whitling AM, Bussey HI, Lyons RM. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation. Arch Intern Med 1998;158(19):2136-40.
21. Taylor CT, Chester EA, Byrd DC, Stephens MA. Vitamin K to reverse excessive anticoagulation: a review of the literature. Pharmacotherapy 1999;19(12):1415-25.
22. Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmacotherapy 2000;20(10):1159-66.
23. Crowther MA, Julian J, McCarty D, Douketis J, Kovacs M, Biagoni L, et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet 2001;356(9241):1551-3.
24. Crowther MA, Douketis JD, Schnurr T, Steidl L, Mera V, Ultori C, et al. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin Kin the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med 2002;137(4):251-4.
25. Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D. Comparison of oral versus intravenous phytonadione (Vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med 2003;163(20):2469-73.
26. Crowther MA, Donovan D, Harrison L, McGinnis J, Ginsberg J. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost 1998;79(6):1116-8.
27. Duong TM, Plowman BK, Morreale AP, Janetzky K. Retrospective and prospective analyses of the treatment of overanticoagulated patients. Pharmacotherapy 1998;18(6):1264-70.
28. Pendry K, Bhavnani M, Shwe K. The use of oral vitamin K for reversal of over-warfarinization [letter]. Br J Haematol 2001;113(3):839-40.
29. Watson HG, Baglin T, Laidlaw SL, Makris M, Preston E. A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol 2001;115(1):145-9.
30. Lousberg TR, Witt DM, Beall DG, Carter BL, Malone DC. Evaluation of excessive anticoagulation in a group model health maintenance organization. Arch Intern Med 1998;158(5):528-34.
31. Glover JJ, Morrill GB. Conservative treatment of overanticoagulated patients. Chest 1995;108(4):987-90.
32. Wilson SE, Douketis JD, Crowther MA. Treatment of warfarin-associated coagulopathy: a physician survey. Chest 2001;120(6):1972-6.
33. Nee R, Doppenschmidt D, Donovan DJ, Andrews TC. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. Am J Cardiol 1999;83(2):286-8.
34. Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med 1999;159(22):2721-4.
35. Martinez-Abad M, Delgado F, Palop V, Morales-Olivas FJ. Vitamin K and anaphylactic shock. Ann Pharmacother 1991;25(7-8):871-2.